12:00 PM EST - MedMira Inc. : announced today that five of the Company's rapid tests for diseases including HIV, H.Pylori, Syphilis, and Hepatitis B and C have been approved for sale in Jordan by that country's Food and Drug Administration. This approval and subsequent product sales mark MedMira's first win in the Middle East, a highly lucrative region where the Company has numerous market development initiatives underway. MedMira Inc.
shares V.MIR are trading up $0.01 at $0.05.
